Twenty years of biologics experience, a modern computational mindset, and strategic advice that helps biotechnology teams make better scientific decisions.
Science. Strategy. Execution.
Every engagement is led directly by me — no junior consultants, no handoffs. You work with an experienced scientist who has spent more than two decades in biologics discovery and development. I bring the strategy, review, and expert judgment; not wet-lab services.
BiotecMaven is a strategic biologics consultancy founded by Dr. Vibha Chauhan, a seasoned biologics scientist with more than 20 years of experience in oncology, antibody engineering, and protein design.
I help biotech startups, pharma teams, and investors make better scientific decisions — supporting therapeutic programs from early discovery through preclinical development. Increasingly, I extend that biology-first expertise with computational biology and AI, applied where they genuinely add insight rather than as a separate practice.
Helping biotechnology companies make better scientific decisions — grounded in biologics expertise, extended with computational biology and AI.
Supporting biologics programs from target evaluation through preclinical development, with expertise spanning antibody engineering, protein design, and translational strategy.
Applying computational methods and artificial intelligence to help organizations interpret complex biological data, evaluate scientific hypotheses, and make better R&D decisions.
For more than two decades, I've helped shape therapeutic programs from the bench toward the clinic — spanning antibody engineering, protein design, and, increasingly, the computational and AI-driven methods reshaping modern drug discovery.
My work has contributed to landmark immuno-oncology therapies and included scientific leadership roles at some of the industry's most respected companies. Today I bring that experience to teams and investors as an independent scientific advisor.
Flexible engagements — as a strategic partner, a fractional advisor, or on a focused project — with deliverables you can put straight to work.
All work is confidential, serving clients across the U.S. and worldwide.
Clear, actionable assessments and program roadmaps.
Technical due-diligence and investor-facing narratives.
Structured analyses you can plug into planning.
Live strategy sessions and ongoing expert input.
Whether you're shaping a new biologics program or evaluating one, I'd be glad to help you think it through.
Based in Silicon Valley, working with biotech, pharma, and investors worldwide.
Send a note about your program and what you're working through — I'll get back to you personally.
Email Me